alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM LIN HOLDINGS
CORP. CONSOLIDATED STATEMENTS OF OPERATIONS AND CONSOLIDATED BALANCE SHEET, AND
IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH LIN HOLDINGS CORP. ANNUAL
REPORT ON FORM 10-Q DATED SEPTEMBER 30, 1999.
</LEGEND>
<CIK> 0001062707
<NAME> LIN HOLDINGS CORP.
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               SEP-30-1999
<CASH>                                          19,746
<SECURITIES>                                         0
<RECEIVABLES>                                   44,621
<ALLOWANCES>                                     1,751
<INVENTORY>                                          0
<CURRENT-ASSETS>                                76,209
<PP&E>                                         154,355
<DEPRECIATION>                                  25,173
<TOTAL-ASSETS>                               1,866,922
<CURRENT-LIABILITIES>                           59,956
<BONDS>                                        532,165
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                     499,608
<TOTAL-LIABILITY-AND-EQUITY>                 1,866,922
<SALES>                                              0
<TOTAL-REVENUES>                               153,616
<CGS>                                                0
<TOTAL-COSTS>                                  136,556
<OTHER-EXPENSES>                                52,800
<LOSS-PROVISION>                                  (73)
<INTEREST-EXPENSE>                              49,171
<INCOME-PRETAX>                               (35,740)
<INCOME-TAX>                                   (3,109)
<INCOME-CONTINUING>                           (32,631)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (32,631)
<EPS-BASIC>                                          0
<EPS-DILUTED>                                        0


</TABLE>
IN RE J.S.

No. COA08-1030.

Court of Appeals of North Carolina.

Filed January 20, 2009.

Certification Date February 9, 2009.

Appeal from Lee (06J71).

Case reported without published opinion. Vacated.
#### In the Matter of James M. Barbato, Appellant, v Sarah M. Proskurenko, Respondent.

(Appeal No. 2.)

[801 NYS2d 182]

Appeal from an order of the Family Court, Onondaga County (David G. Klim, J.), entered November 24, 2004 in a proceeding pursuant to Family Court Act article 6. The order, among other things, awarded primary residential custody of the parties’ child to respondent and visitation to petitioner.

It is hereby ordered that the order so appealed from be and the same hereby is unanimously affirmed without costs.

Memorandum: Family Court properly granted respondent’s cross petition seeking to retain custody of the parties’ child upon the relocation of respondent’s residence to within “200 miles driving distance” of petitioner’s residence. “A custody determination by the trial court must be accorded great deference . . . and should not be disturbed where, as here, it is supported by a sound and substantial basis in the record” *(Matter of Green v Mitchell,*266 AD2d 884, 884 [1999]; *see Matter of Longo v Wright,*19 AD3d 1078 [2005]; *Sorce v Sorce,*16 AD3d 1077 [2005]). Based on the record before us, we conclude that the court properly determined that petitioner is less able than respondent to provide for the child’s stability and well-being *(see*
      *1352
      *Longo,*19 AD3d at 1079; *Matter of Pinkerton v Pensyl,*305 AD2d 1113, 1114 [2003]). We have considered petitioner’s remaining contentions and conclude that they are without merit. Present—Pigott, Jr., P.J., Green, Kehoe, Martoche and Lawton, JJ.
KIRBY, et al. v. NC DEPARTMENT OF TRANSPORTATION.

No. 56PA14-2.

Supreme Court of North Carolina.

Feb. 1, 2016.

Matthew H. Bryant, Winston-Salem, for Kirby, Everette E., et al.

*800Dahr Joseph Tanoury, Associate City Attorney, for North Carolina Department of Transportation.

John F. Oates, Jr., Assistant Attorney General, for North Carolina Department of Transportation.

John F. Maddrey, Solicitor General, for North Carolina Department of Transportation.

T. Paul Hendrick, Winston-Salem, for Kirby, Everette E., et al.

Kenneth C. Otis, III, Winston-Salem, for Kirby, Everette E., et al.

Kenneth A. Shanklin, Wilmington, for Wilmington Urban Area Metropolitan Planning Organization.

Matthew A. Nichols, Wilmington, for Wilmington Urban Area Metropolitan Planning Organization.

Elliot M. Engstrom, Raleigh, for Pacific Legal Foundation and Center for Law and Freedom.

W. Kirk Sanders, Winston-Salem, for Kirby, Everette E., et al.

John L. Wait, High Point, for N.C. Association of Realtors, Inc.

G. Wilson Martin, Jr., for N.C. Association of Realtors, Inc.

Jonathan D. Guze, Durham, for The John Locke Foundation.

Jessica Odom Wilkie, for N.C. Advocates for Justice.

Joshua D. Hansen, for N.C. Advocates for Justice.

Jones P. Byrd, Asheville, for N.C. Advocates for Justice.

Carlene M. McNulty, for N.C. Justice Center.

Mark Miller, Pro Hac Vice, for Pacific Legal Foundation and Center for Law and Freedom.

The following order has been entered on the motion filed on the 27th of January 2016 by Dahr Tanoury to Withdraw:

> "Motion Allowed by order of the Court in conference, this the 1st of February 2016."
Unassociated Document









Exhibit 10.4


 




JOINDER TO


SECURITY AGREEMENT







This Joinder to Security Agreement (“Joinder”) is made on this ________, 2010 (the “Effective Date”) by  ________________ (“Investor”).







WHEREAS, as of the date hereof, Applied DNA Sciences, Inc., a Delaware corporation (the “Company”) has issued and sold to the Investor a senior secured convertible note (the “Investor Note”) in a private placement transaction (the “Offering”);







WHEREAS, as part of the Offering, the Investor will become a party to that certain Security Agreement (the “Security Agreement”), dated as of July 15, 2010 made by the Company in favor of Etico Capital, LLC, a limited liability company organized under the laws of Delaware, as Collateral Agent for the Buyers (as defined in the Security Agreement), pursuant to which the Investor Note will be secured by a security interest in all of the assets of the Company.







NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants and agreements contained herein, the parties hereto agree as follows:


 


1.           Joinder to Security Agreement.  Investor hereby agrees to be become a party to and to be bound by all of the terms and provisions of the Security Agreement as a Buyer for all purposes thereunder.  In addition, the Investor Note will be deemed to be a “Note” (as defined in the Security Agreement).


 


2.           Applicable Law. This Joinder will be construed in accordance with, and the rights of the parties governed by, the laws of the State of New York, without regard to the choice of law provisions thereof.


 


3.           Counterparts; Incorporation.  This Joinder may be executed in any number of counterparts, each of which shall be deemed an original and all of which taken together shall constitute one and the same instrument.  The recitals to this Joinder are hereby incorporated by reference and made a part hereof for all purposes.


 







 


[Remainder of page intentionally left blank]


 




  





  











  






IN WITNESS WHEREOF, the parties hereto have executed this Joinder as of the date first above written.


 




	  	
[INVESTOR]


	  	  
	  	  
	  	
By:_________________________________


	  	
Name:


	  	
Title:














 


AGREED TO AND ACCEPTED:







 


APPLIED DNA SCIENCES, INC.,


a Delaware corporation


 


 


By:_____________________________


Dr. James A. Hayward


President and Chief Executive Officer


 







 


ETICO CAPITAL, LLC.,


a Delaware limited liability corporation


 


 


By:_____________________________


Scott A. Weisman


Managing Director
EXHIBIT 13.1



CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the Annual Report on Form 20-F of Scottish Power plc (the Company) for the fiscal year ended March 31, 2004 as filed with
the Securities and Exchange Commission on the date hereof (the Report) , I, Ian Russell, the Chief Executive Officer of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, to the best of my knowledge, that:



|1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ---------------------------------------------------------------------------------------------------------------------



|2. | The information in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|-- | ------------------------------------------------------------------------------------------------------------------------------------------



Dated: June 25, 2004



/s/ Ian RussellIan RussellChief Executive Officer
# C_2023338EN.01002801.xml

| 25.9.2023 | EN | Official Journal of the European Union | C 338/28 |
| --- | --- | --- | --- |

25.9.2023

EN

Official Journal of the European Union

C 338/28

---

Order of the President of the General Court of 24 July 2023 — Zaklady Farmaceutyczne Polpharma v Commission

(Case T-258/23 R)

(Interim relief - Medicinal products for human use - Marketing authorisation - Application for interim measures - Application for injunction - Lack of urgency)

(2023/C 338/37)

Language of the case: English

Parties

Applicant: Zaklady Farmaceutyczne Polpharma S.A. (Starogard Gdański, Poland) (represented by: K. Roox, T. De Meese, J. Stuyck and C. Dumont, lawyers)

Defendant: European Commission (represented by: E. Mathieu, L. Haasbeek and A. Spina, acting as Agents)

Re:

By its application based on Articles 278 and 279 TFEU, the applicant seeks, in essence, first, suspension of operation of Commission Implementing Decision C(2023) 3067 final of 2 May 2023 amending Commission Implementing Decision C(2014) 601 final of 30 January 2014 granting marketing authorisation (‘MA’) for the medicinal product for human use Tecfidera — Dimethyl fumarate (‘Tecfidera’) under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency (OJ 2004 L 136, p. 1), as amended, and any subsequent decision or act extending or replacing the contested decision in so far as they concern it, and, second, an injunction requiring the European Commission to refrain from taking any other measures which would amount to a withdrawal of the MA enjoyed by it or a prohibition on placing generic Dimethyl fumarate products on the market.

Operative part of the order

| 1. | The application for interim measures is dismissed. |
| --- | --- |

1.

The application for interim measures is dismissed.

| 2. | There is no longer any need to rule on the applications to intervene submitted by Biogen Netherlands BV and Biogaran SAS or on the applications for confidential treatment submitted by Zaklady Farmaceutyczne Polpharma S.A. |
| --- | --- |

2.

There is no longer any need to rule on the applications to intervene submitted by Biogen Netherlands BV and Biogaran SAS or on the applications for confidential treatment submitted by Zaklady Farmaceutyczne Polpharma S.A.

| 3. | The costs relating to the proceedings for interim relief are reserved. |
| --- | --- |

3.

The costs relating to the proceedings for interim relief are reserved.

| 4. | Each party shall bear its own costs relating to the applications to intervene submitted by Biogen Netherlands and Biogaran. |
| --- | --- |

4.

Each party shall bear its own costs relating to the applications to intervene submitted by Biogen Netherlands and Biogaran.

---
<PAGE>


                                  Exhibit 99.1
                                  ------------

                               RESOLUTIONS ADOPTED
                         AT THE AUGUST 28, 2001 MEETING
                          OF THE BOARD OF DIRECTORS OF
                          JOHN Q. HAMMONS HOTELS, INC.

         WHEREAS, the Board previously had a Finance Committee to oversee the
Corporation's finance, accounting and development activities and the Board
desires to re-establish the Finance Committee.

         RESOLVED, that the Board hereby appoints a Finance Committee consisting
of Don Dempsey, Chairman, Dave Sullivan, Jacquie Dowdy and Dan Earley; and

         FURTHER RESOLVED, that the Finance Committee shall: (i) review and make
recommendations to the Board for all Corporation acquisitions of real property
of $1,000,000 or more; (ii) review and make recommendations to the Board for all
Corporation leases that obligate the Corporation for $250,000 or more annually;
(iii) review and make recommendations to the Board for all Corporation
financings of $1,000,000 or more; (iv) review and make recommendations to the
Board for any and all agreements or contracts that obligate the Corporation to
spend $250,000 or more annually; (v) review and make recommendations to the
Board for any and all agreements, arrangements or contracts between the
Corporation and any person who is an officer or director of the Corporation, or
who is directly or indirectly the beneficial owner of more than 10 per centum of
any class of any equity security of the Corporation; (vi) review and make
recommendations to the Board for all sales or purchases of hotel(s) and/or
associated properties; (vii) review and make recommendations to the Board for
the annual budgets for the Corporation; and (viii) review and make
recommendations to the Board for the refinancing of the Corporation's bonds and
maturing bank debt (collectively, the "Corporate Commitments").

                                      * * *

         RESOLVED, that all Corporate Commitments shall be approved by the Board
before the Corporation enters into or undertakes any such Corporate Commitments;
and

         FURTHER RESOLVED, that no officer, agent or representative of the
Corporation has the authority to enter into any Corporate Commitment unless
both: (i) the Finance Committee has reviewed and recommended such Corporate
Commitment to the Board and (ii) the Board has reviewed, approved and authorized
such Corporate Commitment.
<TABLE> <S> <C>

<PAGE>
 
<ARTICLE> 5
       
<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          SEP-30-1998
<PERIOD-START>                             OCT-01-1997
<PERIOD-END>                               SEP-30-1998
<CASH>                                          23,178
<SECURITIES>                                    16,834
<RECEIVABLES>                                   18,595
<ALLOWANCES>                                       260
<INVENTORY>                                          0
<CURRENT-ASSETS>                                59,746
<PP&E>                                           3,205
<DEPRECIATION>                                     834
<TOTAL-ASSETS>                                  74,503
<CURRENT-LIABILITIES>                           10,051
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        62,656
<OTHER-SE>                                       1,516
<TOTAL-LIABILITY-AND-EQUITY>                    74,503
<SALES>                                         57,725
<TOTAL-REVENUES>                                57,725
<CGS>                                                0
<TOTAL-COSTS>                                   37,273
<OTHER-EXPENSES>                                14,658
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 156
<INCOME-PRETAX>                                  6,774
<INCOME-TAX>                                     2,642
<INCOME-CONTINUING>                              4,132
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     4,132
<EPS-PRIMARY>                                      .45
<EPS-DILUTED>                                      .39
        

</TABLE>
STATE v. Jorge JUAREZ.

No. 360P15-1.

Supreme Court of North Carolina.

Oct. 27, 2015.

Emily H. Davis, Assistant Appellate Defender, for Juarez, Jorge.

Isham F. Hicks, Special Deputy Attorney General, for State of North Carolina.

N. Lorrin Freeman, District Attorney, for State of North Carolina.

**Opinion**

The following order has been entered on the motion filed on the 26th of October 2015 by State of NC for Temporary Stay:

> "Motion Allowed by order of the Court in conference, this the 27th of October 2015."
**Exhibit 99.19****CONSENT OF M. BUTCHER**     Reference is made to the Annual Report on Form 40-F and the documents incorporated byreference therein (the “40-F”) of Goldcorp Inc. (the “Company”) for the fiscal year ended December31, 2009, and any amendments thereto, to be filed with the United States Securities and ExchangeCommission pursuant to the United States Securities Exchange Act of 1934, as amended, and theAnnual Information Form (the “AIF”) and Management’s Discussion and Analysis (“MD&A”) of theCompany for the year then ended, which are filed as exhibits to and incorporated by reference inthe 40-F.     I hereby consent to the references to, and the information derived from, the followingreport(s) and to the references, as applicable, to my name in connection with (including, as anexpert) the following report(s) and documents: 1. The technical report dated May 1, 2008, entitled “Pueblo Viejo GoldProject, Dominican Republic Technical Report” (the “Pueblo ViejoReport”);  2. The technical report dated March 10, 2009, entitled “PeñasquitoProject Technical Report” (the “Peñasquito Report”); and  3. The 40-F, the MD&A and the AIF, which include references in connectionwith information relating to the Pueblo Viejo Report, the PeñasquitoReport, the Pueblo Viejo Project and the Peñasquito Project, and theproperties described therein.Date: March 19, 2010              /s/ Murray Butcher     Name:  Murray Butcher, MAusIMM     Consulting Metallurgist
110TH CONGRESS

1ST SESSION S. 487

AN ACT

To amend the National Organ Transplant Act to clarify

that kidney paired donations shall not be considered to

involve the transfer of a human organ for valuable consideration.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. SHORT TITLE.

4 This Act may be cited as the ‘‘Living Kidney Organ

5 Donation Clarification Act of 2007’’.
 †

2

S 487 ES

1 SEC. 2. AMENDMENT TO THE NATIONAL ORGAN TRANS2 PLANT ACT.

3 Section 301(a) of the National Organ Transplant Act

4 (42 U.S.C. 274e(a)) is amended by adding at the end the

5 following: ‘‘For purposes of this section, kidney paired do6 nation shall not be considered to involve the transfer of

7 a human organ for valuable consideration.’’.

8 SEC. 3. REPORT.

9 Not later than 1 year after the date of enactment

10 of this Act, and annually thereafter, the Secretary of

11 Health and Human Services shall submit to the appro12 priate committees of Congress a report that details the

13 progress made towards understanding the long-term

14 health effects of living organ donation.

Passed the Senate February 15, 2007.

Attest:

Secretary.
110TH CONGRESS

1ST SESSION S. 487

AN ACT

To amend the National Organ Transplant Act to

organ for valuable consideration.considered to involve the transfer of a humanclarify that kidney paired donations shall not be
MUCHMORE v. TRASK.

No. 479P08.

Supreme Court of North Carolina.

October 24, 2008.

Tobias S. Hampson, Raleigh, for Muchmore.

Michael S. Harrell, John B. McMillan, Raleigh, for Trask.

*897Prior report: ___ N.C.App. ___, 666 S.E.2d 667.

The following order has been entered on the motion filed on the 21st day of October 2008 by Plaintiff for Temporary Stay:

"Motion Allowed by order of the Court in conference this the 24th day of October 2008."
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Housing and Urban Development

          - [Docket No. FR-4980-N-37]

# AGENCY:

Office of the Assistant Secretary for Community Planning and Development, HUD.

# ACTION:

Notice. 

# SUMMARY:

This Notice identifies unutilized, under utilized, excess, and surplus Federal property reviewed by HUD for suitability for possible use to assist the homeless.

# DATES:

Effective September 16, 2005.

# FOR FURTHER INFORMATION CONTACT:

Kathy Ezzell, Department of Housing and Urban Development, Room 7262, 451 Seventh Street SW., Washington, DC 20410; telephone (202) 708-1234; TTY number for the hearing- and speech-impaired (202) 708-2565, (these telephone numbers are not toll-free), or call the toll-free Title V information line at 1-800-927-7588.

# SUPPLEMENTARY INFORMATION:

                    In accordance with the December 12, 1988 court order in                     *National Coalition for the Homeless*                     v.                     *Veterans Administration,*                     No 88-2503-OG (D.D.C.), HUD publishes a Notice, on a weekly basis, identifying unutilized, underutilized, excess and surplus Federal buildings and real property that HUD has reviewed for suitability for use to assist the homeless. Today's Notice is for the purpose of announcing that no additional properties have been determined suitable or unsuitable this week.                

Dated: September 8, 2005.

Mark R. Johnston,

Director, Office of Special Needs Assistance Programs.

[FR Doc. 05-18172 Filed 9-15-05; 8:45 am]

BILLING CODE 4210-29-M